SpectronRx
Indianapolis
About SpectronRx
SPECTRONRx provides therapeutic and diagnostic isotopes for clinical and research use including theranostics, molecular radiotherapies, and custom manufacturing that provides radionuclides and custom theranostic contract manufacturing like monoclonal antibody labeling, peptides, radiolabeling of molecules and chemical entities, and aptamers. They operate GMP, pharmaceutical-grade Lu-177, Ac-225, and I-131 for various clinical applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $85.0M
- Funding stage: Private Equity
- Last round: Private Equity (Apr 2026)
- Website: spectronrx.com
- Phone: +1 574 271 2800
Social Profiles
Canonical: https://fsome.com/organization/spectronrx-2221718 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.